Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
BIOTECH TARGET N V Insider Profile
11 Followers
BIOTECH TARGET N V, Ten Percent Owner at Cidara Therapeutics, holds 0.00 shares in Molecular Templates (Ticker: MTEM), holds 9.93M shares in MacroGenics (Ticker: MGNX), holds 8.73M shares in Radius Health (Ticker: ~RDUS). Most recently, BIOTECH TARGET N V Sold ― shares of Molecular Templates on Nov 18, 2024 for an estimated value of 844.68K.
BIOTECH TARGET N V Cidara Therapeutics (CDTX)Ten Percent Owner
Cidara Therapeutics (CDTX)
Ten Percent Owner
Ranked #96,690 out of 99,335 Corporate Insiders
Profitable Transactions
18 out of 59 Profitable Transactions
Average Return
-30.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that BIOTECH TARGET N V holds in companies
Most Profitable Insider Trade
The most profitable trade made by BIOTECH TARGET N V
BIOTECH TARGET N V's Trading History
Cidara Therapeutics
Nov 16, 2017
Ten Percent Owner
Informative Buy
453.60K
$34.70M
Esperion
May 26, 2021
Ten Percent Owner
Informative Buy
2.02M
$10.79M
Radius Health
May 20, 2022
―
Informative Buy
2.66M
$88.03M
Molecular Templates
Nov 18, 2024
Ten Percent Owner
Informative Sell
844.68K
$0.00
MacroGenics
Oct 04, 2023
Ten Percent Owner
Informative Buy
669.00K
$32.57M
List of latest transactions for each holding click on a transaction to see BIOTECH TARGET N V's performance on stock
You May Also Like
BIOTECH TARGET N V insider profile FAQ
What is the percentage of profitable transactions made by BIOTECH TARGET N V?
The percentage of profitable transactions made by BIOTECH TARGET N V is 31%.
What is the average return per transaction made by BIOTECH TARGET N V?
The average return per transaction made by BIOTECH TARGET N V is -30.60%.
What stocks does BIOTECH TARGET N V hold?
BIOTECH TARGET N V holds: CDTX, ESPR, ~RDUS, MTEM, MGNX stocks.
What was BIOTECH TARGET N V’s latest transaction?
BIOTECH TARGET N V latest transaction was an Informative Sell of $844.68K.
What was BIOTECH TARGET N V's most profitable transaction?
BIOTECH TARGET N V’s most profitable transaction was an Informative Buy of MGNX stock on February 16, 2023. The return on the trade was 228.50%.
What is BIOTECH TARGET N V's role in Cidara Therapeutics?
BIOTECH TARGET N V's role in Cidara Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.